These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7289632)

  • 41. Enhancement of thrombotic arterial occlusion following cholesterol feeding in the guinea-pig: a role for thromboxane A2.
    Hirata Y; Umemura K; Nakano M; Uematsu T; Nakashima M
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):81-6. PubMed ID: 7972270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation.
    Robertson DN; Page CP
    Br J Pharmacol; 1987 Sep; 92(1):105-11. PubMed ID: 3664082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet aggregation studies in whole human blood.
    Saniabadi AR; Lowe GD; Forbes CD; Prentice CR; Barbenel JC
    Thromb Res; 1983 Jun; 30(6):625-32. PubMed ID: 6412393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM; Forscher CA; Sussman II; Mueller HS
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epinephrine induces Ca2+ uptake in human blood platelets.
    Owen NE; Feinberg H; Le Breton GC
    Am J Physiol; 1980 Oct; 239(4):H483-H488. PubMed ID: 7425140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of aspirin and paracetamol on the aggregation of equine blood platelets.
    Heath MF; Evans RJ; Poole AW; Hayes LJ; McEvoy RJ; Littler RM
    J Vet Pharmacol Ther; 1994 Oct; 17(5):374-8. PubMed ID: 7853463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
    Kakushi H; Shike T; Uchida K
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.
    Thomas M; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade.
    Rao GH; Reddy RK; White JG
    Prostaglandins Med; 1981 May; 6(5):485-94. PubMed ID: 6115432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
    Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
    Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
    Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY
    Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex differences in mouse platelet aggregation.
    Torres Duarte AP; Ramwell P; Myers A
    Thromb Res; 1986 Jul; 43(1):33-9. PubMed ID: 3088759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
    Le Breton GC; Venton DL; Enke SE; Halushka PV
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of phosphoinositide metabolism in potentiation by adrenaline of ADP-induced aggregation of rabbit platelets.
    Lalau Keraly C; Vickers JD; Kinlough-Rathbone RL; Mustard JF
    Biochem J; 1987 Mar; 242(3):841-7. PubMed ID: 3036103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.